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Background
Many NP labs have developed internal strategies for 
standardised extract screening and purification, only 
publishing parts of the overall setup1,2. Most modern NP 
purification methods are based on reverse-phase (RP) 
due to its versatility3,4,5. However facing complex extracts 
with many components, a simple RP strategy can lead to 
poor recoveries. This is especially a problem when 
dealing with low-output extracts, e.g. from the marine 
environment6. For these types of extracts, orthogonal 
purification strategies are requisite7.   
So, we have developed a so-called Explorative Solid-
Phase Extraction (E-SPE) method, which in a fast and easy 
way will indicate the optimum purification strategy on a 
small scale in the exploratory stage of the discovery 
process. This will allow a more rational approach to the 
purification process.
Method setup
To obtain maximum complementarity, four different 
columns were selected. Together they provide information 
on size, charge and polarity of the active components 
needed to develop a purification strategy.
• Strong anion-exchanger (SAX): 
Presence of carboxylic acids
• Mixed-mode (RP) anion-exchanger (MAX):
Presence of acids, enols and phenols
Relative polarity (25, 60, 100% AcCN)
• Strong cation-exchanger (SCX):
Presence of basic amines
• LH-20 for size-exclusion:
Relative size 
A total of 15 fractions for bioassay is generated from 
each extract (1 agar plate or 50 mL of liquid culture). 
Each of the active fractions are subjected to comparative 
dereplication by LC-HRMS. The MS chromatograms for all 
active fractions are compared, and the MS spectra are 
extracted for all peaks in common. The accurate mass is 
then used as query in a database search (AntiBase, 
AntiMarin or similar). This provides a full list of potential 
candidates as well as their likelihood to be novel. 
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Method validation
The E-SPE method was tested on 25 
different marine bacteria with 
antibacterial activities such as growth 
and quorum sensing inhibition. A few 
well-researched filamentous fungi 
were included as further validation. 
Each organism was tested in triplicates 
to ensure reproducibility. 
The method was found to be widely 
applicable on both bacterial and 
fungal samples, however very dependent on the matrix. 
Especially for the marine samples, extensive desalting was 
necessary to ensure reproducibility. Further tests are 
necessary to investigate the robustness of the method as 
well. 
Example - Pseudoalteromonas luteoviolaceae:
A marine bacterium representing a highly complex extract with 
multiple known antibacterials. Nonetheless, the E-SPE 
bioactivity profile against Vibrio anguillarum revealed the 
presence of a potential novel bioactive present in a fraction 
with no known bioactives. E-SPE also provided the information 
that this compound is medium polar with an acidic functionality 
other than COOH.
Above: E-SPE bioactivity profile for Ps. luteoviolaceae showing the distribution of active known 
and unknown compounds against gram-negative Vibrio aguillarum in a well-diffusion assay.  
Bioactivity profile shown as elution matrix from Cardellina et al. 1.
Method implementation
As a proof-of-concept, a purification strategy was 
developed based on the E-SPE activity profile for Ps. 
luteoviolaceae and carried out on extract from 8 L of 
culture. 
Above: UV chromatogram of retained fraction from cation-exchange, further separated by LH-
20 to give pure indolmycin and violacein (ID confirmed by CapNMR) as well as two minor, 
unknown pigments.
Each of the purified compounds were present in sub-
milligram quantities and were therefore subjected to 
CapNMR for increased sensitivity. Besides a series of 3-
butyric acid oligomers, the known antibacterial compound 
indolmycin was identified for the first time in a non-
Streptomyces strain. We are currently awaiting final NMR 
confirmation of a series of unknown compounds as well as 
the rest of the active components.
Conclusions
E-SPE is a successful strategy to reveal novel, bioactive
natural products from both fungal and bacterial sources.
The advantages of E-SPE are many:
 Finding a purification strategy on small amounts 
before engaging semi-preparative purification 
 Identifying possible pit-falls (stability, synergy etc.)
 Reducing false positives (media components, salt etc.)
 Reducing number of candidates for dereplication
(at CMB by LC-UV-HRMS)
 Unmasking potential candidates
 Enables target-guided isolation rather than bio-
guided fractionation
 Standardising the analysis of samples (SOP)
Results obtained on a small scale (a single agar plate or
50 mL of culture) can readily be translated into bigger
scale (200 plates, 10 L culture) for preparative results.
The E-SPE strategy has proven it-self to be fast, easy and
reproducible in use and has therefore been implemented
as a standard screening procedure at CMB when dealing
with new extracts.
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